SCM
Sterling Capital Management Portfolio holdings
AUM
$7.04B
1-Year Return
20.28%
This Quarter Return
-1.56%
1 Year Return
+20.28%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$6.45B
AUM Growth
-$851M
(-12%)
Cap. Flow
-$582M
Cap. Flow
% of AUM
-9.02%
Top 10 Holdings %
Top 10 Hldgs %
23.85%
Holding
3,274
New
31
Increased
484
Reduced
2,296
Closed
55
Top Buys
| 1 |
Linde
LIN
|
+$106M |
| 2 |
Accenture
ACN
|
+$64.3M |
| 3 |
Rockwell Automation
ROK
|
+$38.1M |
| 4 |
Booz Allen Hamilton
BAH
|
+$23.8M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$12.8M |
Top Sells
| 1 |
Hershey
HSY
|
+$97.4M |
| 2 |
Raymond James Financial
RJF
|
+$86.8M |
| 3 |
Microchip Technology
MCHP
|
+$80.2M |
| 4 |
Merck
MRK
|
+$28M |
| 5 |
Global Payments
GPN
|
+$27.9M |
Sector Composition
| 1 | Technology | 21.56% |
| 2 | Financials | 17.84% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 9.06% |
| 5 | Consumer Discretionary | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Arrowhead Research
ARWR
$4.28B
| $1.55K | ﹤0.01% |
122
| – | – |
|
2602
Lyell Immunopharma
LYEL
$251M
| $1.55K | ﹤0.01% |
144
-129
| -47% | -$1.39K |
|
2603
Arhaus
ARHS
$1.52B
| $1.55K | ﹤0.01% |
178
-119
| -40% | -$1.04K |
|
|
CBLL
2604
CeriBell, Inc. Common Stock
CBLL
$424M
| $1.54K | ﹤0.01% |
80
-55
| -41% | -$1.06K |
|
2605
Twin Disc
TWIN
$184M
| $1.52K | ﹤0.01% |
201
-178
| -47% | -$1.35K |
|
2606
Rigel Pharmaceuticals
RIGL
$677M
| $1.51K | ﹤0.01% |
84
-57
| -40% | -$1.03K |
|
2607
Phreesia
PHR
$1.46B
| $1.51K | ﹤0.01% |
59
| – | – |
|
2608
Ingevity
NGVT
$2.13B
| $1.5K | ﹤0.01% |
38
| – | – |
|
2609
AvidXchange
AVDX
$2.06B
| $1.5K | ﹤0.01% |
177
| – | – |
|
|
PLL
2610
DELISTED
Piedmont Lithium
PLL
| $1.5K | ﹤0.01% |
238
-208
| -47% | -$1.31K |
|
2611
Savara
SVRA
$622M
| $1.5K | ﹤0.01% |
540
-319
| -37% | -$884 |
|
2612
Puma Biotechnology
PBYI
$230M
| $1.5K | ﹤0.01% |
505
-421
| -45% | -$1.25K |
|
2613
Rocky Brands
RCKY
$217M
| $1.49K | ﹤0.01% |
86
-74
| -46% | -$1.29K |
|
2614
GoPro
GPRO
$313M
| $1.49K | ﹤0.01% |
2,249
-2,002
| -47% | -$1.33K |
|
2615
IES Holdings
IESC
$7.47B
| $1.49K | ﹤0.01% |
9
+1
| +13% | +$165 |
|
2616
IDEAYA Biosciences
IDYA
$2.19B
| $1.47K | ﹤0.01% |
90
+5
| +6% | +$82 |
|
2617
Apogee Therapeutics
APGE
$2.24B
| $1.46K | ﹤0.01% |
39
| – | – |
|
|
RAPP
2618
Rapport Therapeutics
RAPP
$855M
| $1.45K | ﹤0.01% |
145
+2
| +1% | +$20 |
|
|
RGLS
2619
DELISTED
Regulus Therapeutics
RGLS
| $1.45K | ﹤0.01% |
830
-788
| -49% | -$1.38K |
|
2620
iRobot
IRBT
$108M
| $1.45K | ﹤0.01% |
537
-374
| -41% | -$1.01K |
|
2621
OneSpan
OSPN
$586M
| $1.43K | ﹤0.01% |
94
-55
| -37% | -$839 |
|
2622
Sezzle
SEZL
$3.01B
| $1.43K | ﹤0.01% |
41
-19
| -32% | -$663 |
|
2623
Korro Bio
KRRO
$299M
| $1.43K | ﹤0.01% |
82
-64
| -44% | -$1.12K |
|
2624
Fate Therapeutics
FATE
$114M
| $1.42K | ﹤0.01% |
1,799
-1,601
| -47% | -$1.27K |
|
2625
LifeMD
LFMD
$275M
| $1.42K | ﹤0.01% |
261
-209
| -44% | -$1.14K |
|